Orgenesis Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was USD 0.141 million compared to USD 0.142 million a year ago. Net loss was USD 9.77 million compared to USD 19.47 million a year ago.

Basic loss per share from continuing operations was USD 0.29 compared to USD 0.87 a year ago. Diluted loss per share from continuing operations was USD 0.29 compared to USD 0.87 a year ago.